Frontlight ResearchEarly access
Trial site
Krankenhaus der Elisabethinen Linz
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Melanoma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals1 trial
- Pierre Fabre Medicament1 trial
Running trials
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Site data: ClinicalTrials.govUpdated 12 Nov 2026